Skip to main content
TipRanks
Go Ultimate75% OFF

Capricor Therapeutics (4LN2) Ownership - Who Owns Capricor Therapeutics?

0 Followers

Capricor Therapeutics (4LN2) Ownership Overview

  • 0.93% Insiders
  • 7.61% Mutual Funds
  • 0.62% Other Institutional Investors
  • 12.24% ETFs
  • 78.60% Public Companies and Individual Investors

The ownership structure of Capricor Therapeutics (DE:4LN2) stock is a mix of institutional, retail, and individual investors. Approximately 20.47% of the company’s stock is owned by Institutional Investors, 0.93% is owned by Insiders, and 78.60% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Dec 31, 2025Goalvest Advisory Llc€59,163
Dec 31, 2025Woodline Partners Lp€6,322,821
Dec 31, 2025Ra Capital Management€43,516,377

Top Shareholders

DE:4LN2 top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.4,145,061Institution7.13%41,143,875
Vanguard2,769,947Institution4.76%27,494,494
Vanguard Index Funds2,246,873Institution3.86%22,302,461
Ishares2,077,862Institution3.57%20,624,858
Spdr2,047,867Institution3.52%20,327,128
Peter Kolchinsky1,507,844Institution2.59%14,966,860
Fidelity Salem Street Trust646,025Institution1.11%6,412,444
Vanguard Scottsdale Funds371,326Institution0.64%3,685,782
Fidelity Concord Street Trust347,831Institution0.60%3,452,571
Linda Marban211,104Insider0.36%2,095,418

Top Mutual Fund Holders

DE:4LN2 top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds2,246,873Institution3.86%22,302,461
Fidelity Salem Street Trust646,025Institution1.11%6,412,444
Vanguard Scottsdale Funds371,326Institution0.64%3,685,782
Fidelity Concord Street Trust347,831Institution0.60%3,452,571
Tiaa-cref Funds177,039Institution0.30%1,757,289
Schwab Capital Trust160,898Institution0.28%1,597,074
Vanguard World Fund140,884Institution0.24%1,398,415
Jpmorgan Trust I48,562Institution0.08%482,026
Vanguard Explorer Fund40,091Institution0.07%397,943
Vanguard Valley Forge Funds25,820Institution0.04%256,289

FAQ

Who Owns Capricor Therapeutics (DE:4LN2)?
According to the latest TipRanks data, approximately 20.47% of the company's stock is held by institutional investors, 0.93% is held by insiders, and 78.60% is held by public companies and individual investors.
What percentage of Capricor Therapeutics (DE:4LN2) stock is held by institutional investors?
According to the latest TipRanks data, approximately 20.47% of Capricor Therapeutics (DE:4LN2) stock is held by institutional investors: 7.61% by mutual funds, 12.24% by ETFs and 0.62% by other institutional investors.
What percentage of Capricor Therapeutics (DE:4LN2) stock is held by retail investors?
According to the latest TipRanks data, approximately 78.60% of Capricor Therapeutics (DE:4LN2) stock is held by public companies and individual investors.
Who owns the most shares of Capricor Therapeutics (DE:4LN2)?
BlackRock, Inc. owns the most shares of Capricor Therapeutics (DE:4LN2).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.